查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600094

医疗保健市场开拓受託製造厂商市场：按服务、最终用户划分 - 2025-2030 年全球预测

Healthcare Contract Development & Manufacturing Organization Market by Services, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医疗保健市场价值为3063.8亿美元，预计到2024年将达到3319.9亿美元，复合年增长率为8.84%，到2030年将达到5543.9亿美元。

医疗保健合约开发和受託製造厂商(CDMO) 市场包括为製药和生物技术公司提供的各种服务，包括药物开发、临床试验管理和商业规模製造。由于製药公司在不需要大量内部投资的情况下降低成本、缩短时间和获得专业知识的压力越来越大，对此类服务的需求正在增加。 CDMO 在药物研发过程中发挥关键作用，提供灵活的解决方案，促进创新、监管合规和治疗进步。最终用途范围广泛，从小分子药物到生技药品，涉及肿瘤学、神经病学和感染疾病等领域。

主要市场统计
基准年[2023] 3063.8亿美元
预测年份 [2024] 3319.9亿美元
预测年份 [2030] 5543.9亿美元
复合年增长率（%） 8.84%

根据市场洞察，CDMO产业受到生技药品需求增加、复杂技术平台需求以及严格监管要求等因素的显着影响。生物相似药以及细胞和基因疗法的最新进展提供了有希望的成长机会。公司可以利用这些机会，加强先进治疗方法的能力并扩大服务范围，以适应个人化医疗的趋势。然而，许多限制仍然存在，包括严格的监管监督、供应链复杂性和品质保证挑战。最迫切的挑战之一是维持生产扩充性的高标准，这需要对品管系统和基础设施进行大量投资。

需要创新的领域包括将人工智慧和机器学习整合用于药物开发中的预测分析、提高製造效率的自动化以及最大限度地减少环境影响的永续生产实践等。持续的製造流程研究有可能透过降低成本和提高品质来进一步革新生产。市场本质上是竞争性的，CDMO 必须灵活应对快速变化的药物开发环境。透过专注于策略伙伴关係关係、投资最尖端科技并确保遵守全球监管标准，Masu 可以确保持续成长并在这个充满活力的市场中保持竞争力。

市场动态：揭示快速发展的医疗保健市场的关键市场洞察

供需的动态交互作用正在改变医疗保健市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于慢性病的增加对生技药品的需求增加
    • 依赖先进製造能力的复杂医疗保健治疗的增加
  • 市场限制因素
    • 医疗 CDMO 服务营运成本高
  • 市场机会
    • 采用创新技术提升 CDMO 服务效率
    • 与生技公司策略联盟提供CDMO服务
  • 市场挑战
    • CDMO 服务的严格监管审查

波特五力：驾驭医疗保健市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解医疗保健市场的外部影响

外部宏观环境因素在塑造医疗保健市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解医疗保健市场的竞争状况

医疗保健市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵医疗保健市场供应商的绩效评估

FPNV 定位矩阵是评估医疗保健市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製医疗保健市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，医疗保健市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于慢性病的增加，对生物製药的需求不断增加
      • 依赖先进製造能力的复杂医疗程序的增加
    • 抑制因素
      • 医疗CDMO服务营运成本高
    • 机会
      • 引进创新技术提高CDMO服务效率
      • 与生技公司策略联盟提供CDMO服务
    • 任务
      • CDMO服务的严格监管
  • 市场区隔分析
    • 服务：增加最终剂量製剂的使用，重点在于特种药物和生技药品
    • 最终用户：大型製药公司越来越多地采用 CDMO 服务来支援大规模临床和商业生产
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 医疗保健市场开拓受託製造厂商市场：依服务分类

  • 合约开发
    • 高分子
      • 细胞株开发
      • 製程开发
    • 小分子
      • 临床
      • 第一阶段
      • 第二阶段
      • 第三阶段
      • 第四阶段
      • 化验服务
      • 分析服务
      • 生物分析服务
      • 临床前
      • 生物分析和 DMPK 研究
      • 其他临床前服务
      • 毒性试验
  • 契约製造
    • 最终剂量配方
    • 高效API
    • 高分子
    • 医疗设备
    • 小分子

第七章 医疗保健市场开拓受託製造厂商市场：依最终使用者分类

  • 大型製药公司
  • 学名药公司
  • 中小型製药企业

第八章 北美和南美医疗保健市场开拓受託製造厂商市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区医疗保健市场开拓受託製造厂商市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲医疗保健市场开拓受託製造厂商市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FUJIFILM投资 12 亿美元扩建霍利斯普林斯的生技工厂
    • FUJIREBIO Holdings 与 Agappe Diagnostics 签署 CDMO 合作伙伴关係，以本地生产化学冷光解决方案
    • Enzen Biosciences 在美国开设首个製造地，以扩大生技伙伴关係和市场占有率
  • 战略分析和建议

公司名单

  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Corden Pharma International GmbH
  • Curia Global, Inc.
  • Eurofins Scientific SE
  • EVER company group
  • Evonik Industries AG
  • FUJIFILM Diosynth Biotechnologies
  • Jabil, Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • MedPharm Ltd.
  • Merck KGaA
  • Piramal Group
  • Porton Pharma Solutions Ltd
  • Recipharm AB
  • Samsung Biologics
  • Sanmina Corporation
  • Siegfried Holding AG
  • Siegfried-Group
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec
Product Code: MRR-B812DD5799E8

The Healthcare Contract Development & Manufacturing Organization Market was valued at USD 306.38 billion in 2023, expected to reach USD 331.99 billion in 2024, and is projected to grow at a CAGR of 8.84%, to USD 554.39 billion by 2030.

The scope of the healthcare contract development and manufacturing organization (CDMO) market encompasses a variety of services tailored towards pharmaceutical and biotechnology companies, including drug development, clinical trial management, and commercial-scale production. The growing necessity for these services continues to be driven by increasing pressure on pharmaceutical companies to reduce costs, accelerate timelines, and access specialized expertise without extensive in-house investment. CDMOs play a crucial role in drug research and development processes, offering flexible solutions that facilitate innovation, regulatory compliance, and therapeutic advancement. The end-use scope is vast, covering everything from small molecule drugs to biologics, and extending to sectors including oncology, neurology, and infectious diseases.

KEY MARKET STATISTICS
Base Year [2023] USD 306.38 billion
Estimated Year [2024] USD 331.99 billion
Forecast Year [2030] USD 554.39 billion
CAGR (%) 8.84%

Market insights reveal that the CDMO industry is significantly influenced by factors such as the rise in demand for biologics, the need for sophisticated technology platforms, and stringent regulatory requirements. Recent advancements in biosimilars and cell and gene therapies present promising opportunities for growth. Companies can capitalize on these opportunities by enhancing capabilities in advanced therapeutic modalities and expanding service offerings to cater to personalized medicine trends. Nonetheless, limitations such as high regulatory scrutiny, supply chain complexities, and quality assurance challenges remain prevalent. One of the most pressing challenges is maintaining high standards amid production scalability, which necessitates substantial investment in quality management systems and infrastructure.

Areas ripe for innovation include the integration of AI and machine learning for predictive analytics in drug development, automation for improved efficiency in manufacturing, and sustainable production practices to minimize environmental impact. Research into continuous manufacturing processes could further revolutionize production by reducing costs and improving quality. The market is intrinsically competitive, requiring CDMOs to be agile and adaptive to rapidly changing drug development landscapes. By focusing on strategic partnerships, investing in cutting-edge technologies, and ensuring compliance with global regulatory standards, CDMOs can secure sustained growth and maintain a competitive edge in this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Contract Development & Manufacturing Organization Market

The Healthcare Contract Development & Manufacturing Organization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for biologics with increasing prevalence of chronic diseases
    • Rising complex healthcare treatments with the reliance on advanced manufacturing capabilities
  • Market Restraints
    • High operational costs of healthcare CDMO services
  • Market Opportunities
    • Adoption of innovative technologies that enhance the efficiency of CDMO services
    • Strategic partnerships with biotech firms for CDMO services
  • Market Challenges
    • Stringent regulatory scrutiny for CDMO services

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Contract Development & Manufacturing Organization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Contract Development & Manufacturing Organization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Contract Development & Manufacturing Organization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Contract Development & Manufacturing Organization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Contract Development & Manufacturing Organization Market

A detailed market share analysis in the Healthcare Contract Development & Manufacturing Organization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Contract Development & Manufacturing Organization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Contract Development & Manufacturing Organization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Contract Development & Manufacturing Organization Market

A strategic analysis of the Healthcare Contract Development & Manufacturing Organization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Development & Manufacturing Organization Market, highlighting leading vendors and their innovative profiles. These include Baxter International, Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent Inc., Charles River Laboratories International, Inc., Corden Pharma International GmbH, Curia Global, Inc., Eurofins Scientific SE, EVER company group, Evonik Industries AG, FUJIFILM Diosynth Biotechnologies, Jabil, Inc., Laboratory Corporation of America Holdings, Lonza Group AG, MedPharm Ltd., Merck KGaA, Piramal Group, Porton Pharma Solutions Ltd, Recipharm AB, Samsung Biologics, Sanmina Corporation, Siegfried Holding AG, Siegfried-Group, Thermo Fisher Scientific, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Development & Manufacturing Organization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Contract development and Contract manufacturing. The Contract development is further studied across Large Molecule and Small Molecule. The Large Molecule is further studied across Cell Line development and Process Development. The Small Molecule is further studied across Clinical, Laboratory Services, and Preclinical. The Clinical is further studied across Phase I, Phase II, Phase III, and Phase IV. The Laboratory Services is further studied across Analytical Services and Bioanalytical Services. The Preclinical is further studied across Bioanalysis and DMPK studies, Other Preclinical Services, and Toxicology Testing. The Contract manufacturing is further studied across Finished Dose Formulations, High Potency API, Large Molecule, Medical Devices, and Small Molecule.
  • Based on End-User, market is studied across Big Pharmaceutical Companies, Generic Pharmaceutical Companies, and Small & Medium-Sized Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for biologics with increasing prevalence of chronic diseases
      • 5.1.1.2. Rising complex healthcare treatments with the reliance on advanced manufacturing capabilities
    • 5.1.2. Restraints
      • 5.1.2.1. High operational costs of healthcare CDMO services
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of innovative technologies that enhance the efficiency of CDMO services
      • 5.1.3.2. Strategic partnerships with biotech firms for CDMO services
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory scrutiny for CDMO services
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Growing usage of finished dose formulations with the focus on specialty medicine and biologics
    • 5.2.2. End-User: Rising adoption of CDMO services by big pharmaceutical companies to support large-scale clinical and commercial manufacturing
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Contract Development & Manufacturing Organization Market, by Services

  • 6.1. Introduction
  • 6.2. Contract development
    • 6.2.1. Large Molecule
      • 6.2.1.1. Cell Line development
      • 6.2.1.2. Process Development
    • 6.2.2. Small Molecule
      • 6.2.2.1. Clinical
      • 6.2.2.1.1. Phase I
      • 6.2.2.1.2. Phase II
      • 6.2.2.1.3. Phase III
      • 6.2.2.1.4. Phase IV
      • 6.2.2.2. Laboratory Services
      • 6.2.2.2.1. Analytical Services
      • 6.2.2.2.2. Bioanalytical Services
      • 6.2.2.3. Preclinical
      • 6.2.2.3.1. Bioanalysis and DMPK studies
      • 6.2.2.3.2. Other Preclinical Services
      • 6.2.2.3.3. Toxicology Testing
  • 6.3. Contract manufacturing
    • 6.3.1. Finished Dose Formulations
    • 6.3.2. High Potency API
    • 6.3.3. Large Molecule
    • 6.3.4. Medical Devices
    • 6.3.5. Small Molecule

7. Healthcare Contract Development & Manufacturing Organization Market, by End-User

  • 7.1. Introduction
  • 7.2. Big Pharmaceutical Companies
  • 7.3. Generic Pharmaceutical Companies
  • 7.4. Small & Medium-Sized Pharmaceutical Companies

8. Americas Healthcare Contract Development & Manufacturing Organization Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Development & Manufacturing Organization Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Development & Manufacturing Organization Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. FUJIFILM Corporation Invests USD 1.2 Billion to Expand Biotech Facility in Holly Springs
    • 11.3.2. Fujirebio Holdings and Agappe Diagnostics Form CDMO Partnership for Local Chemiluminescence Solution Production
    • 11.3.3. Enzene Biosciences Establishes First U.S. Manufacturing Site to Boost Biotech Partnerships and Market Presence
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Baxter International, Inc.
  • 2. Boehringer Ingelheim International GmbH
  • 3. Cambrex Corporation
  • 4. Catalent Inc.
  • 5. Charles River Laboratories International, Inc.
  • 6. Corden Pharma International GmbH
  • 7. Curia Global, Inc.
  • 8. Eurofins Scientific SE
  • 9. EVER company group
  • 10. Evonik Industries AG
  • 11. FUJIFILM Diosynth Biotechnologies
  • 12. Jabil, Inc.
  • 13. Laboratory Corporation of America Holdings
  • 14. Lonza Group AG
  • 15. MedPharm Ltd.
  • 16. Merck KGaA
  • 17. Piramal Group
  • 18. Porton Pharma Solutions Ltd
  • 19. Recipharm AB
  • 20. Samsung Biologics
  • 21. Sanmina Corporation
  • 22. Siegfried Holding AG
  • 23. Siegfried-Group
  • 24. Thermo Fisher Scientific, Inc.
  • 25. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY OTHER PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY HIGH POTENCY API, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 239. E